Literature DB >> 15827040

Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy.

D Ashok, W H Ayliffe, P D W Kiely.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827040     DOI: 10.1093/rheumatology/keh635

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  7 in total

Review 1.  Biologic therapy for refractory scleritis: a new treatment perspective.

Authors:  Tania Sales de Alencar de Fidelix; Luis Antonio Vieira; Denise de Freitas; Virginia Fernandes Moça Trevisani
Journal:  Int Ophthalmol       Date:  2015-08-29       Impact factor: 2.031

2.  Successful treatment of severe nodular scleritis with adalimumab.

Authors:  Juan P Restrepo; María P Molina
Journal:  Clin Rheumatol       Date:  2010-02-14       Impact factor: 2.980

Review 3.  [Diseases of the outer eye in rheumatoid arthritis].

Authors:  E Feist; U Pleyer
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

Review 4.  Ocular inflammatory diseases associated with rheumatoid arthritis.

Authors:  Mathieu Artifoni; Pierre-Raphaël Rothschild; Antoine Brézin; Loïc Guillevin; Xavier Puéchal
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

5.  Necrotising scleritis and connective tissue disease--three cases and a review.

Authors:  Sharmin Nizam; Annette Johnstone; Michael Green; Andrew Gough
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980

6.  Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy.

Authors:  Sara Benchérifa; Bouchra Amine; Imane El Binoune; Samira Rostom; Rachid Bahiri
Journal:  BMC Rheumatol       Date:  2020-02-07

Review 7.  Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives.

Authors:  Veronique Promelle; Vincent Goeb; Julie Gueudry
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.